Autologous Fat Grafting Techniques in Patients Undergoing Reconstructive Surgery

NCT ID: NCT02677012

Last Updated: 2020-07-14

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

50 participants

Study Classification

OBSERVATIONAL

Study Start Date

2016-02-04

Study Completion Date

2020-07-03

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This randomized clinical trial studies and compares 3 techniques in performing autologous fat grafting (AFG) in patients undergoing surgery to reshape or rebuild (reconstruct) a part of the body changed by previous surgery and inserted into another part of the body. AFG, also called fat injections or fat transplant, is a procedure in which an individual's own body fat (usually from abdomen or legs) is used during reconstructive surgery. Doctors want to compare 3 techniques for processing the fat tissue collected during surgery and the length of time needed to complete each AFG technique and surgery. Comparing 3 AFG techniques and the time to complete them during surgery may help doctors determine the best technique to perform fat grafting in the future.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

PRIMARY OBJECTIVES:

I. Measure and compare the rate of fat processed, defined as the volume of fat processed per unit time associated with the use of three aforementioned adipose tissue processing techniques.

SECONDARY OBJECTIVES:

I. To measure total fat grafting time: time from initiation of fat harvesting to the end of fat injection.

II. To measure volume of fat processed: volume of fat obtained after fat processing.

III. To measure total operation room (OR) time: time from patient entry into the OR (or when the patient barcode is read on entering the OR) to the time at which the patient leaves the OR.

OUTLINE: Patients are randomized to 1 of 3 arms.

ARM I (REVOLVE TM): Patients undergo AFG reconstructive surgery comprising washing and low velocity spinning using a commercially available system that washes the lipoaspirate with lactated Ringer's solution separates non-fat material from the fat with gentle centrifugal force and suction.

ARM II (CYTORI PUREGRAT TM): Patients undergo AFG reconstructive surgery comprising gravity filtration using a commercially available system in which the lipoaspirate is rinsed with lactated Ringer's solution (RL) and the non-fat material is filtered through mesh.

ARM III (COLEMAN TECHNIQUE): Patients undergo AFG reconstructive surgery comprising standard centrifugation at 3200 revolutions per minute (rpm) for 3 minutes with the resulting oil and aqueous layers discarded.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Health Status Unknown

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Arm I (RESOLVE TM)

Patients undergo AFG reconstructive surgery comprising washing and low velocity spinning using a commercially available system that washes the lipoaspirate with lactated Ringer's solution separates non-fat material from the fat with gentle centrifugal force and suction.

Autologous Fat Graft

Intervention Type PROCEDURE

Undergo AFG using the RESOLVE TM technique

Reconstructive Surgery

Intervention Type PROCEDURE

Undergo reconstructive surgery

Arm II (Cytori PureGraft TM)

Patients undergo AFG reconstructive surgery comprising gravity filtration using a commercially available system in which the lipoaspirate is rinsed with lactated RL and the non-fat material is filtered through mesh.

Autologous Fat Graft

Intervention Type PROCEDURE

Undergo AFG using the Cytori PureGraft TM technique

Reconstructive Surgery

Intervention Type PROCEDURE

Undergo reconstructive surgery

Arm III (Coleman technique)

Patients undergo AFG reconstructive surgery comprising standard centrifugation at 3200 rpm for 3 minutes with the resulting oil and aqueous layers discarded.

Autologous Fat Graft

Intervention Type PROCEDURE

Undergo AFG using the Coleman technique

Reconstructive Surgery

Intervention Type PROCEDURE

Undergo reconstructive surgery

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Autologous Fat Graft

Undergo AFG using the RESOLVE TM technique

Intervention Type PROCEDURE

Autologous Fat Graft

Undergo AFG using the Cytori PureGraft TM technique

Intervention Type PROCEDURE

Autologous Fat Graft

Undergo AFG using the Coleman technique

Intervention Type PROCEDURE

Reconstructive Surgery

Undergo reconstructive surgery

Intervention Type PROCEDURE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Autologous Fat Cell Transplantation Autologous Fat Injection Autologous Fat Transfer Autologous Fat Cell Transplantation Autologous Fat Injection Autologous Fat Transfer Autologous Fat Cell Transplantation Autologous Fat Injection Autologous Fat Transfer Reconstruction

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with available harvest sites for fat grafting
* Patients with body mass index (BMI) \> 20
* Estimated harvested fat volume \>= 100 cc
* Patients are willing and able to give consent

Exclusion Criteria

* Patients with active cancer, including primary cancer, recurrent cancer, or locally or distant metastasis
* Patients who are unable to provide consent
* Patients who are suspected or known to be pregnant
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Cancer Institute (NCI)

NIH

Sponsor Role collaborator

M.D. Anderson Cancer Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Summer Hanson

Role: PRINCIPAL_INVESTIGATOR

M.D. Anderson Cancer Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

M D Anderson Cancer Center

Houston, Texas, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Hanson SE, Garvey PB, Chang EI, Reece GP, Liu J, Baumann DP, Butler CE. A Randomized Prospective Time and Motion Comparison of Techniques to Process Autologous Fat Grafts. Plast Reconstr Surg. 2021 May 1;147(5):1035-1044. doi: 10.1097/PRS.0000000000007827.

Reference Type DERIVED
PMID: 33890883 (View on PubMed)

Related Links

Access external resources that provide additional context or updates about the study.

http://www.mdanderson.org

MD Anderson Cancer Center Website

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NCI-2016-00346

Identifier Type: REGISTRY

Identifier Source: secondary_id

2015-0006

Identifier Type: OTHER

Identifier Source: secondary_id

P30CA016672

Identifier Type: NIH

Identifier Source: secondary_id

View Link

2015-0006

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Postoperative Electrical Muscle Stimulation Two
NCT06964438 NOT_YET_RECRUITING NA
Refeeding Syndrome in Cancer Patients
NCT02534181 WITHDRAWN PHASE2
Nutrition to Support Postoperative Recovery
NCT07109505 NOT_YET_RECRUITING NA